Search
MaxCyte Inc
MXCTAdd to Watchlist
1.485USD
-0.105-6.60%
Market hours 11/02, 13:37（ET）
153.27MMarket Cap
LossP/E TTM
Today
-6.60%
5 Days
+6.07%
1 Month
+36.24%
6 Months
+68.75%
Year to Date
-4.19%
1 Year
-3.57%
Key Figures
1.610Open
1.720High
118.17KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.11%Turnover Ratio
1.590Prev. Close
1.485Low
190.16KTurnover
LossP/E Static
0.96P/B
0.00%Div Yield TTM
-18.43%ROA
1.80552wk High
0.14Volume Ratio
-41.05MNet Profit
103.21MShares
-0.3669EPS TTM
1.45Beta
-21.30%ROE
0.64352wk Low
14.78%Amplitude
69.19%Gross Margin
153.27MMarket Cap
3.05Reward/Risk
4.60%Risk Rate
MaxCyte Inc's Score
-0.01vs previous score
Forecast8.67
Financial Health6.42
Technical6.40
Valuation Dimensions7.72
Institutional Confidence7.00
Risk Assessment2.79
Media Coverage
Coverage Level
Very Low
Very High
Positive
Analyst Rating
MaxCyte Inc Technical Analysis
Technical Indicators
Neutral
Summary
Neutral
Moving Average
Buy
MaxCyte Inc Latest Earnings Call Transcripts
MaxCyte (MXCT) Q2 2026 Earnings Call: Guidance Reaffirmed as Genentech Partnership Expands
MaxCyte Q2 2026 revenue fell 15% to $7.3 million, while costs declined and 2026 guidance was maintained. Genentech and DTx support second-half growth.
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.08/-0.09
Revenue / Forecast
7.27M/6.48M
MaxCyte Inc Profile
SectorHealthcare Equipment & Supplies
Ticker SymbolMXCT
Number of employees114
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Capricorn Fund Managers Ltd | 7.65% |
| BlackRock Institutional Trust Company, N.A. | 6.96% |
| River Global Investors LLP | 5.13% |
| Vitruvian Partners LLP | 4.71% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 28.60% |
| Investment Advisor/Hedge Fund | 20.75% |
| Hedge Fund | 8.15% |
| Private Equity | 4.71% |
Related Instruments
-2.38%
-1.73%
+3.60%
-1.17%
+2.83%
+2.31%
+4.56%
-1.73%
-1.33%
-1.64%
-0.75%
+1.26%
+4.50%
-6.82%
+0.83%
+0.22%
+20.14%
-0.05%
-1.01%
-2.19%Popular Instruments
52281.200
+492.300 (+0.95%)
28383.000
-23.600 (-0.08%)
7605.200
+22.100 (+0.29%)
12844.000
+59.000 (+0.46%)
63196.000
+868.000 (+1.39%)
6170.000
+49.100 (+0.80%)
95.416
-7.012 (-6.85%)
336.300
-8.330 (-2.42%)
206.390
+1.750 (+0.85%)
3959.160
+84.450 (+2.18%)
FAQs
What is the current price of MaxCyte Inc (MXCT)?
The current price of MaxCyte Inc (MXCT) is 1.59.
What is the symbol of MaxCyte Inc?
The ticker symbol of MaxCyte Inc is MXCT.
What is the 52-week high of MaxCyte Inc?
The 52-week high of MaxCyte Inc is 1.80.
What is the 52-week low of MaxCyte Inc?
The 52-week low of MaxCyte Inc is 0.64.
What is the market capitalization of MaxCyte Inc?
The market capitalization of MaxCyte Inc is 164.10M.
Is MaxCyte Inc (MXCT) currently rated as Buy, Hold, or Sell?
According to analysts, MaxCyte Inc (MXCT) has an overall rating of Buy, with a price target of 4.11.
What is the Earnings Per Share (EPS TTM) of MaxCyte Inc (MXCT)?
The Earnings Per Share (EPS TTM) of MaxCyte Inc (MXCT) is -0.37.